225 related articles for article (PubMed ID: 20085229)
21. In vitro potency and stability of fortified ophthalmic antibiotics.
Arici MK; Sümer Z; Güler C; Elibol O; Saygi G; Cetinkaya S
Aust N Z J Ophthalmol; 1999 Dec; 27(6):426-30. PubMed ID: 10641902
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology and susceptibilities to mercury preservatives of staphylococci isolated from used eye-drops preserved with thiomersal.
Du Bois SK; Davison AL; Pinney RJ
J Pharm Pharmacol; 1995 Mar; 47(3):193-6. PubMed ID: 7602479
[TBL] [Abstract][Full Text] [Related]
23. Compatibility and stability of linezolid injection admixed with three cephalosporin antibiotics.
Xu QA; Trissel LA; Williams KY
J Am Pharm Assoc (Wash); 2000; 40(4):509-14. PubMed ID: 10932460
[TBL] [Abstract][Full Text] [Related]
24. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
Psathas PA; Kuzmission A; Ikeda K; Yasuo S
Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
[TBL] [Abstract][Full Text] [Related]
25. Optimising concentrations of antimicrobial agents in pharmaceutical preparations: Case of an oral solution of glycerol and an ophthalmic solution containing cysteamine.
Chan Hew Wai A; Becasse P; Tworski S; Pradeau D; Planas V
Ann Pharm Fr; 2014 Nov; 72(6):415-21. PubMed ID: 25438652
[TBL] [Abstract][Full Text] [Related]
26. Stability of intravenous admixtures containing aztreonam and cefazolin.
Riley CM; James MJ
Am J Hosp Pharm; 1986 Apr; 43(4):925-7. PubMed ID: 3706339
[TBL] [Abstract][Full Text] [Related]
27. [Antimicrobial Effects of Iodine-Polyvinyl Alcohol Ophthalmic and Eye Washing Solution (PA * IODO) with Special Reference to its Temperature, Concentration and Time and its Preservation Stability].
Hatano H; Sakamoto M; Hayashi K; Kamiya S
Nippon Ganka Gakkai Zasshi; 2015 Aug; 119(8):503-10. PubMed ID: 26390575
[TBL] [Abstract][Full Text] [Related]
28. Stability and antibacterial potency of ceftazidime and vancomycin eyedrops reconstituted in BSS against Pseudomonas aeruginosa and Staphylococcus aureus.
Karampatakis V; Papanikolaou T; Giannousis M; Goulas A; Mandraveli K; Kilmpasani M; Alexiou-Daniel S; Mirtsou-Fidani V
Acta Ophthalmol; 2009 Aug; 87(5):555-8. PubMed ID: 18700884
[TBL] [Abstract][Full Text] [Related]
29. Stability of cefazolin sodium in peritoneal dialysis solutions.
Nahata MC; Ahalt PA
Am J Hosp Pharm; 1991 Feb; 48(2):291-2. PubMed ID: 2003503
[TBL] [Abstract][Full Text] [Related]
30. [Development of formulation of hipromellose eye drops (artificial tears)].
Inkeniene AM; Klimas R; Briedis V; Maciulevicius J
Medicina (Kaunas); 2003; 39(1):77-82. PubMed ID: 12576769
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the preserving efficacy of lubricant eye drops with a novel preservative system.
Rosenthal RA; Buck SL; Henry CL; Schlech BA
J Ocul Pharmacol Ther; 2006 Dec; 22(6):440-8. PubMed ID: 17238811
[TBL] [Abstract][Full Text] [Related]
32. [Studies on hyaluronic acid as dendifier in Shuanghuanglian eye-drops].
Ma ML; Liu L; Sun SY
Zhongguo Zhong Yao Za Zhi; 2005 Aug; 30(16):1246-8. PubMed ID: 16245899
[TBL] [Abstract][Full Text] [Related]
33. Characterisation of a preservative system in an oily preparation.
De Spiegeleer B; Wattyn E; Slegers G; Veys P; Derrieu G; Van Vooren L
Pharmazie; 2006 Jun; 61(6):545-51. PubMed ID: 16826975
[TBL] [Abstract][Full Text] [Related]
34. Storage of extemporaneously prepared ophthalmic antimicrobial solutions.
Charlton JF; Dalla KP; Kniska A
Am J Health Syst Pharm; 1998 Mar; 55(5):463-6. PubMed ID: 9522930
[TBL] [Abstract][Full Text] [Related]
35. [Pros and cons of preservatives in eyedrops. Questionnaire for practitioners and experimental studies with reference to the requirements of the German Pharmacopoeia of August 1978].
Conrads H; Winterhoff D; Strotmann U
Klin Monbl Augenheilkd; 1984 Mar; 184(3):233-7. PubMed ID: 6727243
[TBL] [Abstract][Full Text] [Related]
36. Time- and temperature-dependent stability of growth factor peptides in human autologous serum eye drops.
Bradley JC; Simoni J; Bradley RH; McCartney DL; Brown SM
Cornea; 2009 Feb; 28(2):200-5. PubMed ID: 19158565
[TBL] [Abstract][Full Text] [Related]
37. Are multidose over-the-counter artificial tears adequately preserved?
Charnock C
Cornea; 2006 May; 25(4):432-7. PubMed ID: 16670481
[TBL] [Abstract][Full Text] [Related]
38. Stability of cefazolin sodium admixtures in plastic bags after thawing by microwave radiation.
Tomecko GW; Kleinberg ML; Latiolais CJ; Prior RB; Pesko LJ; Jones BC
Am J Hosp Pharm; 1980 Feb; 37(2):211-5. PubMed ID: 7361792
[TBL] [Abstract][Full Text] [Related]
39. Potency and Sterility of Fortified Tobramycin, Fortified Vancomycin, and Moxifloxacin at 4, 24, and 35°C for 14 Days.
Montes JA; Johnson D; Jorgensen J; McElmeel ML; Fulcher LC; Kiel JW
Cornea; 2016 Jan; 35(1):122-6. PubMed ID: 26555587
[TBL] [Abstract][Full Text] [Related]
40. Generic benzalkonium chloride-preserved travoprost eye drops are not identical to the branded polyquarternium-1-preserved travoprost eye drop: Effect on cultured human conjunctival goblet cells and their physicochemical properties.
Hedengran A; Freiberg JC; Hansen PM; Jacobsen J; Larsen SW; Harloff-Helleberg S; Freude K; Boix-Lemonche G; Petrovski G; Heegaard S; Kolko M
Acta Ophthalmol; 2022 Nov; 100(7):819-827. PubMed ID: 35527390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
